Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Unbranded HCP APS
-
Good afternoon,
Hypothetically, might it be acceptable to develop an unbranded APS directed to HCP with an educational focus on an emerging therapeutic technology, given that i) the APS would have no mention of or linkage to any condition or therapeutic area, ii) the technology is not exclusively applied to one therapeutic area, and iii) such technology is already utilized in pharmaceuticals that have been approved in Canada?
Thank you.
-
Good afternoon,
Hypothetically, might it be acceptable to develop an unbranded APS directed to HCP with an educational focus on an emerging therapeutic technology, given that i) the APS would have no mention of or linkage to any condition or therapeutic area, ii) the technology is not exclusively applied to one therapeutic area, and iii) such technology is already utilized in pharmaceuticals that have been approved in Canada?
Thank you.
Hello @colin
This sounds like it might be possible in an APS that is both product and disease agnostic but it is difficult to say with confidence without knowing the emerging technology, it’s approved applications, the discussions within the piece and their implications to current or future therapeutic areas etc. If the specific example cannot be provided in a public forum, an opinion may be a better option.
